Guide to Targeted Therapies: EGFR mutations in NSCLC (eBook)
XI, 67 Seiten
Springer International Publishing (Verlag)
978-3-319-03059-3 (ISBN)
Federico Cappuzzo, MD, has been the Director of the medical oncology department at the Istituto Toscano Tumori-Ospedale Civile-Livorno in Livorno, Italy since January 2010. In November 1992, he graduated, summa cum laude, in medicine and surgery at the Palermo University. In November 1996, he gained a degree, summa cum laude, in medical oncology at Milan University, followed by the European Society for Medical Oncology (ESMO) certification in medical oncology in 1997. From 1997 to 1999, he was recipient of an ESMO Fellowship on Gene Therapy of Lung Cancer at Institut Gustave Roussy in Villejuif (Paris). He then was an attending physician at the thoracic oncology unit at the Medical University of South Carolina in Charleston from April 2000 to September 2000. For six years, from November 2000 to 2006, he was an assistant professor at Ospedale Bellaria in Bologna. From November 2006 to January 2010, Dr Cappuzzo was an assistant professor in medical oncology at Istituto Clinico Humanitas IRCCS in Rozzano (Milan), and from January 2004 to November 2004 he was a visiting associate professor in medical oncology at University of Colorado in Denver.
Dr Cappuzzo is a member of the Italian Association in Medical Oncology (AIOM), ESMO, American Society Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASCL), and since 2006 has been a member of the editorial board of Lung Cancer. In 2006 and 2009, he received research grants from the Italian Association for Cancer Research (AIRC) on targeted therapies in lung cancer and is the author of more than 130 papers in peer-review journals, mainly in translational research in lung cancer.
Federico Cappuzzo, MD, has been the Director of the medical oncology department at the Istituto Toscano Tumori-Ospedale Civile-Livorno in Livorno, Italy since January 2010. In November 1992, he graduated, summa cum laude, in medicine and surgery at the Palermo University. In November 1996, he gained a degree, summa cum laude, in medical oncology at Milan University, followed by the European Society for Medical Oncology (ESMO) certification in medical oncology in 1997. From 1997 to 1999, he was recipient of an ESMO Fellowship on Gene Therapy of Lung Cancer at Institut Gustave Roussy in Villejuif (Paris). He then was an attending physician at the thoracic oncology unit at the Medical University of South Carolina in Charleston from April 2000 to September 2000. For six years, from November 2000 to 2006, he was an assistant professor at Ospedale Bellaria in Bologna. From November 2006 to January 2010, Dr Cappuzzo was an assistant professor in medical oncology at Istituto Clinico Humanitas IRCCS in Rozzano (Milan), and from January 2004 to November 2004 he was a visiting associate professor in medical oncology at University of Colorado in Denver.Dr Cappuzzo is a member of the Italian Association in Medical Oncology (AIOM), ESMO, American Society Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASCL), and since 2006 has been a member of the editorial board of Lung Cancer. In 2006 and 2009, he received research grants from the Italian Association for Cancer Research (AIRC) on targeted therapies in lung cancer and is the author of more than 130 papers in peer-review journals, mainly in translational research in lung cancer.
Introduction.- The Human Epidermal growth factor Receptor (HER) family: structure and function.- Methods for EGFR mutation testing.- Predictive and prognostic implications of EGFR mutations.- EGFR-targeted therapies in non‑small cell lung cancer.- Conclusions.
| Erscheint lt. Verlag | 25.9.2014 |
|---|---|
| Zusatzinfo | XI, 67 p. 16 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
| Medizinische Fachgebiete ► Innere Medizin ► Pneumologie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| Schlagworte | Epidermal growth factor receptor • Non-small cell lung cancer • Oncology • pharmacotherapy • Pulmonology |
| ISBN-10 | 3-319-03059-0 / 3319030590 |
| ISBN-13 | 978-3-319-03059-3 / 9783319030593 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 2,4 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
